-
-
Original Article
Mosquito Nets and Survival to Adulthood in Tanzania
G. Fink and Others
Hypothetically, in high-transmission settings, malaria control in early childhood might delay acquisition of functional immunity and shift child deaths from younger to older age. This 22-year study of early-life malaria control in such a setting showed that the survival benefit from early-life use of treated nets persisted to adulthood.
Feb 03Editorial Insecticide-Treated Nets and the Persistence of Childhood Survival Gains to Adulthood
-
-
-
Editorial
Covid-19 Update for February 1
Studying Long Covid
E.J. Rubin and Others
In this audio interview conducted on February 1, the editors are joined by Cliff Rosen, a principal investigator in the NIH-funded RECOVER initiative’s study of long Covid, to discuss the potential post-acute sequelae of SARS-CoV-2 infection.
Feb 03 -
Perspective
Challenges in Inferring Omicron’s Severity
R.P. Bhattacharyya and W.P. Hanage
Omicron’s spread in South Africa has led to fewer hospitalizations and deaths per documented case than were seen during previous waves. But caution is warranted when it comes to making inferences about omicron’s intrinsic severity using population-level observations.
Feb 02
-
Editorial
Covid-19 Update for February 1
Studying Long Covid
E.J. Rubin and Others
-
-
Perspective
Using Economics to Inform Public Health Policy
T. Green and A.S. Venkataramani
Although public health practitioners and researchers focus primarily on improving health, economists view health as but one important component of what people may value. This insight is a key aspect of economics’ utility for informing public health policy.
Jan 29 -
Perspective
Automatic Insurance Policies
A. McIntyre and M. Shepard
Policies that broaden eligibility for affordable coverage, though necessary, do little to address the administrative burdens involved in securing and maintaining coverage. Automatic insurance policies could remove barriers and make it easier for people to stay insured.
Jan 29
-
Perspective
Using Economics to Inform Public Health Policy
T. Green and A.S. Venkataramani
-
-
Clinical Decisions
Neonatal Resuscitation
C.D. Lee, L. Nelin, and E.E. Foglia
This interactive feature about infants born very prematurely offers a case vignette accompanied by two essays supporting resuscitation in all neonates born at 22 weeks’ gestation or selective resuscitation. Vote and comment.
Jan 27 -
Interactive Medical Case
Up in the Air
J.V. Loewenthal and Others
This interactive case features a 58-year-old man who reports having crushing, substernal chest pain that starts immediately after a plane’s takeoff. Test your diagnostic and therapeutic skills.
Jan 27
-
Clinical Decisions
Neonatal Resuscitation
C.D. Lee, L. Nelin, and E.E. Foglia
-
Learn More
Covid-19 Vaccine Resource Center
Practical guidance for your practice and patients
Original Research
-
-
Original Article
Gene Therapy for β-Thalassemia
F. Locatelli and Others
Of 23 patients with transfusion-dependent β-thalassemia who received gene-transfected autologous hematopoietic cells, 91% became transfusion independent; the remaining 2 patients had a low level of engraftment of vector-expressing cells. With a median of 29.5 months of follow-up, the average hemoglobin level was 11.7 g per deciliter.
Feb 03Editorial Efficacy and Safety of Gene Therapy for β-Thalassemia
-
-
-
Original Article
Lenvatinib–Pembrolizumab in Advanced Endometrial Cancer
V. Makker and Others
Women with advanced endometrial cancer that progressed during platinum-containing therapy were randomly assigned to lenvatinib plus pembrolizumab or physician’s choice of chemotherapy (doxorubicin or paclitaxel). The median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months and 11.4 months, respectively.
Feb 03 -
Original Article
Immune Checkpoint Therapy in Esophageal Cancer
Y. Doki and Others
Previously untreated patients with advanced esophageal cancer were randomly assigned to receive chemotherapy alone, chemotherapy plus nivolumab, or nivolumab plus ipilimumab. Among patients with tumor-cell PD-L1 expression of 1% or greater, the two nivolumab regimens resulted in longer overall survival than chemotherapy. The side-effect profile was consistent with past reports on these agents.
Feb 03
-
Original Article
Lenvatinib–Pembrolizumab in Advanced Endometrial Cancer
V. Makker and Others
-
-
Correspondence
Neutralization of Omicron with Third Vaccine Dose
I. Nemet and Others
Serum samples from 20 participants who had received two doses of the BNT162b2 vaccine and from 20 who had received three doses were assessed for ability to neutralize the omicron variant of SARS-CoV-2 in vitro. Neutralization activity was poor after two vaccine doses. However, substantial neutralization of the omicron variant was detected in samples from participants who had received three doses.
Feb 03
-
Correspondence
Neutralization of Omicron with Third Vaccine Dose
I. Nemet and Others
-
-
Correspondence
Preliminary Data on Vaccine Protection against Omicron
S. Collie and Others
Using a test-negative study design focused on the period of dominance of the B.1.1.529 (omicron) variant in South Africa, investigators found that two doses of the BNT162b2 vaccine had an efficacy of 50 to 70% against hospitalization caused by omicron in Gauteng province.
Feb 03
-
Correspondence
Preliminary Data on Vaccine Protection against Omicron
S. Collie and Others
-
Explore NEJM Evidence, a new digital journal
Read the FREE first issue with innovative original research and bold ideas in clinical trial design and clinical decision-making.
Clinical Practice and Review
-
-
Clinical Problem-Solving
Calm before the Storm
M.B. Braga Neto and Others
A 61-year-old man was evaluated after having jaundice, light-colored stools, dark urine, pruritus, fatigue, and a temperature of up to 39°C (without chills) for 1 week. He had dull pain in the right upper quadrant of the abdomen and had nausea but no vomiting. Six weeks before jaundice developed, he had been hospitalized with Covid-19. What is the diagnosis?
Feb 03 -
Review Article
High-Altitude Travel with Medical Problems
A.M. Luks and P.H. Hackett
Travel to high altitude is increasing. The authors discuss physiological changes at high altitude, pretravel evaluation for common medical conditions, and the risks of high-altitude headache, acute mountain sickness, high-altitude pulmonary edema, and high-altitude cerebral edema.
Jan 27 -
Perspective
The Care I Needed
J. Gregg
When a physician finds herself in pain and in need of health care, she discovers both the frustrations of telehealth and some moments of humanity and grace with physicians and patients alike. How do we reconcile these healing moments with our broken system of care?
Feb 03
-
Clinical Problem-Solving
Calm before the Storm
M.B. Braga Neto and Others
-
-
Review Article
Fever of Unknown Origin
G. Haidar and N. Singh
FUO despite a high-quality workup after a reasonable amount of time has elapsed to rule out self-limited fevers remains a challenge. The clinician must pay close attention to the patient history, aided by the development of molecular diagnostic tests, to distinguish infections from other causes.
Feb 03 -
Case Records of the Massachusetts General Hospital
A Boy with Fever, Joint Pain, and Abdominal Cramping
K. Zanger and Others
A 14-year-old boy was admitted with fatigue, fever, joint pain, abdominal cramping, and diarrhea. He had been well until 2 weeks earlier, when fatigue and fever developed on his final day of summer camp. On the day of admission, he had pain in his shoulders and knees and a temperature of 39.2°C. What is the diagnosis?
Jan 27
-
Featured Multimedia
Commentary
-
Racial Biology and Medical Misconceptions
A. Deyrup and J.L. Graves -
Beyond Diversity — Time for New Models of Health
J.L. Delgado -
Roulette
T.J. McGarrity -
Efficacy and Safety of Gene Therapy for β-Thalassemia
E. Payen -
Insecticide-Treated Nets and the Persistence of Childhood Survival Gains to Adulthood
T.P. Eisele and L. Slutsker -
Reviewers for the Journal, July–December 2021
E.J. Rubin -
Diabetes Technology — Polling Results
J. O’Connell and OthersRead the polling results analysis, located in the Comments.


